| Literature DB >> 35643461 |
Victor Housset1,2, Philippe Anract3, Antoine Babinet3, Guillaume Auberger3, David Biau3.
Abstract
INTRODUCTION: Extra-articular resection (EAR) of the hip joint is prone to significant complications and morbidity. Thus, this study evaluates the cumulative incidences and main reasons of reoperation following EAR of primary malignant bone tumors (PMBT) of the hip to determine whether the outcomes are different between EAR of the pelvis and that of the proximal femur. PATIENTS AND METHODS: Thirty-three patients presented with a PMBT of the proximal femur or pelvis were included in this study. Among all PMBTs, 58% originated from the pelvis and 42% were from the proximal femur. Twenty patients had chondrosarcomas (61%), 10 had osteosarcomas (30%), and 3 had sarcomas of another histological subtype (9%).Entities:
Mesh:
Year: 2022 PMID: 35643461 PMCID: PMC9145149 DOI: 10.1186/s12957-022-02642-x
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 3.253
Fig. 1On the left, proximal femur pathologic fracture on a chondrosarcoma. On the right, extraarticular resection and reconstruction with an endoprosthetic reconstruction and ice-cream cone prosthesis performed for the same patient. The posterior column was preserved
Fig. 2On the left, zone 2 and 3 pelvis chondrosarcoma. On the right, extraarticular resection and reconstruction with an ice-cream cone prosthesis and standard cemented femoral stem performed for the same patient
Characteristics of the population
| Characteristics | Total ( | Femur ( | Pelvis ( | |
|---|---|---|---|---|
| Median age (Q1–Q3) | 52 (44 to 61) | 52 (42 to 58) | 52 (45 to 62) | 0.99 |
| ASA Physical Status Score | 0.65 | |||
| I | 15 (46) | 5 (36) | 10 (52) | |
| II | 12 (36) | 6 (43) | 6 (32) | |
| III | 6 (18) | 3 (21) | 3 (16) | |
| Localization | - | |||
| Pelvis | 19 (58) | - | 19 (100) | |
| Proximal femur | 14 (42) | 14 (100) | - | |
| Enneking and Dunham | - | |||
| I–II | 3 (16) | - | - | |
| I–II–III | 6 (32) | - | - | |
| II–III | 10 (52) | - | - | |
| Average size in mm (Q1-Q3) | 80 (50 to 110) | 85 (49 to 128) | 79 (52 to 100) | 0.37 |
| Histology | 0.11 | |||
| Chondrosarcoma | 20 (61) | 6 (43) | 14 (74) | |
| Ewing sarcoma | 1 (3) | - | 1 (5) | |
| Ostéosarcoma | 10 (30) | 7 (50) | 3 (16) | |
| Other sarcoma | 2 (6) | 1 (7) | 1 (5) | |
| Preoperative metastasis | 0.17 | |||
| No | 31 (94) | 12 (86) | 19 (100) | |
| Yes | 2 (6) | 2 (14) | 0 (0) | |
| Preoperative radiation | 1 | |||
| No | 31 (94) | 13 (93) | 18 (95) | |
| Yes | 2 (6) | 1 (7) | 1 (5) | |
| Preoperative chemotherapy | 0.057 | |||
| No | 23 (70) | 7 (50) | 16 (84) | |
| Yes | 10 (30) | 7 (50) | 3 (16) | |
| Articular contamination (imaging) | 0.37 | |||
| No | 5 (15) | 1 (7) | 4 (21) | |
| Yes | 28 (85) | 13 (93) | 15 (79) | |
ASA Physical Status Score: American Society of Anaesthesiologists physical status classification
Fig. 3Cumulative incidence of revision for any reason, for mechanical reason, for infection, and local recurrence
Fig. 4Cumulative incidences of revision for pelvis EAR and proximal femur EAR
Total number and ratio for each complication encounter from the procedure to the last follow-up for total population, proximal femur, and pelvis tumors, respectively
| Total ( | Pelvis ( | Femur ( | |||||||
|---|---|---|---|---|---|---|---|---|---|
| No. complication | No. patient | % (range) | No. complication | No. patient | % (range) | No. complication | No. patient | % (range) | |
| Revision surgeries any causes | 29 | 17 | 51.5 % | 22 | 13 | 68.4 % | 7 | 4 | 28.6% |
| Mechanical complication | 6 | 5 | 15.1 % | 2 | 2 | 10.5 % | 4 | 3 | 21.4 % |
| Dislocation reduced under anesthesia | 3 | 3 | 9 % | 0 | 0 | 0 | 3 | 3 | 21.4 % |
| Total dislocation | 13 | 9 | 27.3 % | 3 | 3 | 15.8 % | 10 | 6 | 42.9% |
| Other mechanical revision | 3 | 2 | 6 % | 2 | 2 | 10.5 % | 1 | 1 | 7.1 % |
| Total infection | 12 | 9 | 27.3 % | 10 | 8 | 42.1 % | 2 | 1 | 7.1% |
| Wound surgeries | 3 | 2 | 6 % | 3 | 2 | 10.5 % | 0 | 0 | 0 % |
| Deep infection | 9 | 7 | 21.2 % | 7 | 6 | 31.6 % | 2 | 1 | 7.1 % |
| Local recurrence | 7 | 4 | 12.1 % | 7 | 4 | 21 % | 0 | 0 | 0 % |
| Other surgeries | 4 | 4 | 3 % | 1 | 1 | 5.3 % | 0 | 0 | 0 |
| Neurological complication | 2 | 2 | 6 % | 2 | 2 | 10.5 % | 0 | 0 | 0% |
| Hematoma | 1 | 1 | 3 % | 1 | 1 | 5.3 % | 0 | 0 | 0 |
| Parietal complication | 1 | 1 | 3 % | 1 | 1 | 5.3 % | 0 | 0 | 0 |
| Oncologic surgery | 7 | 4 | 15.1 % | 7 | 4 | 21 % | 0 | 0 | 0 % |
| Per-operative complication | 8 | 5 | 15.1 % | 7 | 4 | 21 % | 1 | 1 | 7.1% |
| Capsular effraction | 8 | 8 | 24.2 % | 2 | 2 | 10.5 % | 6 | 6 | 42.9 % |
| Non R0 margin | 3 | 3 | 9% | 3 | 3 | 15.8% | 0 | 0 | 0 % |